GLP-1 drugs like Ozempic aren't just suppressing appetite — they appear to be dampening the brain's entire motivation system.

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...

In a 12-week randomized phase IIa trial in adults with obesity, the dual GLP-1/GLP-2 receptor agonist dapiglutide was well ...

People on Ozempic and similar drugs are spontaneously starting to exercise — not because anyone told them to, but because neuroscientists believe these medications are quietly rewiring how the brain ...

BACKGROUND: Novel treatments are needed for the primary and secondary prevention of heart failure in patients with type 2 diabetes, including individuals with and those without a history of heart ...

The gastric balloon is billed as an alternative for people with obesity who don’t want bariatric surgery or weight-loss drugs. How does it work and does it get the same results?

Appetite doesn't begin in the stomach. It begins in the brain. When you start a GLP-1 medication, the first shifts happe ...

Bacteria in the gut may influence how GLP-1 receptor agonists work. This could help explain why patients do not respond ...

The latest medical science reveals that healthy weight loss doesn't require special genes, diets, or exercise programs. The ...

GLP-1 drugs for weight loss are growing in popularity in the U.S. and across the world. Here's what some users say about their experiences with the medicines.

Researchers find that tirzepatide (Mounjaro) reduces alcohol consumption by 50% and prevents relapse by blunting the brain's reward system.